Indivior Pharmaceuticals, Inc. (INDV)

34.95 +0.08 (+0.23%) USD  |  NASDAQ  |  Aug 31, 16:00
34.95 0.00 (0.00%) After-Hours: 20:00
More

Indivior Pharmaceuticals Cash from Operations (Annual) : -27.00M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for INDV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2011. Start Trial.
Date Value
December 31, 2025 -27.00M
December 31, 2024 36.00M
December 31, 2023 -300.00M
December 31, 2022 -4.00M
December 31, 2021 353.00M
December 31, 2020 -193.00M
December 31, 2019 151.00M
December 31, 2018 303.00M
Date Value
December 31, 2017 295.00M
December 31, 2016 407.00M
December 31, 2015 320.00M
December 31, 2014 440.00M
December 31, 2013 791.00M
December 31, 2012 866.00M
December 31, 2011 715.00M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Supernus Pharmaceuticals, Inc. 47.33M
Liquidia Corp. -35.69M
Corcept Therapeutics, Inc. 142.00M
Prestige Consumer Healthcare, Inc. 257.63M
Harrow, Inc. 43.86M